3D Cell Culture Conference

SAE Media Group's 6th Annual 3D Cell Culture Conference took place on 8-9 February 2023 at the Copthorne Tara Hotel, Scarsdale Place, Kensington, London, United Kingdom.

About

The conference brings together industry experts from big pharma, regulatory bodies and cutting-edge research groups to discuss the challenges and drivers of complex in-vitro model technologies. The programme covers the latest innovations in 3D cell culture models, real-world examples of clinical applications, and insights into regulatory validation and high-throughput screening.

Themes

• 3D cell culture models, spheroids and organoids
• Organ-on-a-chip, lab-on-a-chip and microphysiological systems
• Microfluidics, scaffolding and bioprinting
• Cell-based assays, toxicology and safety assessment
• Translational, personalised and precision-medicine applications
• Regulatory validation and high-throughput screening

Who attends

Pharmaceutical and biotech teams (team leaders, principal investigators, cell and molecular scientists, chief scientific officers, heads of complex in-vitro models, toxicologists), academia, solution providers and regulatory organisations.

Featured speakers (2023 edition)

• Elad Katz, Lead, Navigate Precision Biology, University of Dundee
• Masato Ohbuchi, Senior Researcher, Astellas Pharma Inc.
• Philip Hewitt, Global Head of Early Investigative Toxicology, Merck Healthcare KGaA
• Scott MacDonnell, Director, New Target Interrogation Group, Regeneron Pharmaceuticals

Sponsors

CelVivo, Leica Microsystems, Newcells Biotech, Promega and Systemic Bio.

Venue

Copthorne Tara Hotel, Scarsdale Place, Kensington, London, United Kingdom - a four-star hotel with 745 sq m of flexible meeting space (Shannon Suite and Liffey Suite), two minutes' walk from High Street Kensington underground station.

Organiser

SAE Media Group (SMG) - events@saemediagroup.com - +44 (0)20 7827 6000.

The global 3D cell culture market was predicted to reach USD 3.48 billion by 2028, reflecting growing demand for in-vitro tissue models for drug discovery, pathology modelling and validation, safety and toxicity testing. Organ-on-chip, microphysiological systems and patient-derived tissues are among the fastest-growing areas of the field.